Self-assembling synthetic nanoadjuvant scaffolds cross-link B cell receptors and represent new platform technology for therapeutic antibody production is a research paper published in Science Advances (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI141196
National Institutes of Health
Grant: R01 AI154458
National Institutes of Health
Grant: R01 AI127565
NIAID NIH HHS
Grant: R01 AI040196
National Institutes of Health
Grant: 1R01AI127565-01A1
Nanovaccine-Mediated Immune Protection Against Influenza Virus
National Institutes of Health
Grant: 5R01AI154458-05
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
National Institutes of Health
Grant: 5R01AI141196-02
Universal room temperature stable influenza nanovaccine
Nanovaccine Institute, Iowa State University
FWCI
1.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of “Just right” combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation
Additional file 1 of “Just right” combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation